Patents by Inventor HENRY JOSEPH LEGERE, III

HENRY JOSEPH LEGERE, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11935657
    Abstract: A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: March 19, 2024
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11915810
    Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider. Some of these aspects also provide healthcare providers the ability to electronically send prescriptions and provide users the ability to use a mobile application to send prescriptions to pharmacies to be filled.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 27, 2024
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20240019425
    Abstract: A method for collection and dissemination of biologic data, comprising collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips, assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value, receiving the test results at a server disposed on a network, wherein the server has configured thereon a database, assigning a unique identification to the biologic sample, storing the unique identification in the database, storing the test results in the database in association with the unique identification of the biologic sample, and providing access to the database to healthcare organizations for analysis of the test results.
    Type: Application
    Filed: January 31, 2023
    Publication date: January 18, 2024
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III
  • Patent number: 11867635
    Abstract: A method for performing a diagnostic test comprises generating a first visual trigger on a display screen of a mobile device responsive to activation of an application on the mobile device. An image of a diagnostic test presently viewed by a camera incorporated with the mobile device is displayed on the display screen of the mobile device. The diagnostic test has a second visual trigger thereon. The image and the first visual trigger are displayed on the display screen at a same time. An image is captured by the application of the diagnostic test responsive to alignment of the first visual trigger with the second visual trigger on the display screen of the mobile device. The captured image is processed to provide test results for the diagnostic test.
    Type: Grant
    Filed: December 4, 2020
    Date of Patent: January 9, 2024
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11802868
    Abstract: A method for providing variable function medical tests, comprising providing by a mobile device application a plurality of selectable medical test functions, receiving information from the mobile device application regarding test results from a test performed using a testing device, wherein the testing device includes an alignment target disposed on the testing device and a plurality of immunoassay test strips receiving at the server an image of the testing device from the mobile device application, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing by the server the single value to a control value stored on the server, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: October 31, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11693002
    Abstract: A method for image analysis of medical test results, comprising receiving information from a mobile device application regarding a test performed using a testing device, wherein the testing device includes a plurality of immunoassay test strips and at least one test function indicator on a surface thereof, wherein the mobile device application is configured to recognize the at least one test function indicator to trigger performance of one or more of the plurality of medical test functions, receiving at the server an image of the testing device from the mobile device application, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing the single value to a control value, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: July 4, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11682207
    Abstract: A system and method are provided for presenting self-diagnostic test instructions in the form of audiovisual messages. The system and method include collecting by a user of a testing device a biologic sample for use with a testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects of the system and method present test instructions to the user in the form of audiovisual messages. The audiovisual messages are provided to the user as a response to an interaction with a retail diagnostic product. In some aspects, the complete audiovisual message is presented before the user may complete a self-diagnostic test.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: June 20, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11651866
    Abstract: A method for initiating a telemedicine conference on a mobile device is provided. The method comprises receiving diagnostic test results in response to a diagnostic test, determining if the diagnostic test results include a positive result, storing the diagnostic test results on a server disposed on a network, presenting, if the diagnostic test results are positive, a telemedicine initiation option on a screen of the mobile device, determining whether the telemedicine initiation option is selected, sending the diagnostic test results from the server to the telemedicine provider, sending additional medical history information to the telemedicine provider, and initiating a telemedicine conference with the telemedicine provider. Some of these aspects also provide healthcare providers the ability to electronically send prescriptions and provide users the ability to use a mobile application to send prescriptions to pharmacies to be filled.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: May 16, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11605450
    Abstract: A method for generating a treatment plan in response to medical test results is provided. The method comprises requesting point-of-care (POC) services from a mobile POC unit, receiving at a server confirmation of delivery of POC services to a patient, receiving at the server one or more test results as a result of operation of a medical testing device used in the POC services, wherein the one or more test results includes a determination of the efficacy and dosage level of a medication, generating at the server an updated digital patient record reflecting the one or more test results, and transmitting by the server to a medical entity a treatment plan based on the efficacy and dosage level determined for the medication, wherein the treatment plan is a dosage regimen for the medication.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: March 14, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11599908
    Abstract: A system and method are provided for collection and testing of a biologic sample in a self-diagnostic test. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects include a mobile application operating on a mobile device with which the user interacts. These aspects allow advertisements and other messages to be presented to the user through the mobile application. Some aspects present different messages to the user based on the type of self-diagnostic test the user is conducting.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: March 7, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11594337
    Abstract: A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: February 28, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11587658
    Abstract: A method for a microfluidic testing device includes pumping a portion of a biologic sample into each of a first plurality of parallel pathways from the first reservoir using a micro-pump, applying a separate treatment agent of the plurality of treatment agents within each of the first plurality of parallel pathways to the portion of the biologic sample within the parallel pathway, pumping a second portion of the biologic sample into a selected second parallel pathway associated with a determined treatment agent of a second plurality of parallel pathways from the first reservoir using a second micro-pump, applying the determined treatment agent at a plurality of different dosage levels within the selected second parallel pathway to the second portion of the biologic sample within the selected second parallel pathway, and determining a dosage level of the plurality of different dosage levels of the determined treatment agent providing the treatment efficacy.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: February 21, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11579145
    Abstract: A method for image analysis of medical test results, comprising receiving, at a server, information from a mobile device regarding test results from a test performed using a testing device, wherein the testing device includes an alignment target disposed on the testing device and a plurality of immunoassay test strips, receiving at the server an image of the testing device from the mobile device, determining by the server RGB values for a plurality of pixels of the image, normalizing by the server the RGB values into a single value, comparing by the server the single value to a control value stored on the server, and providing by the server a risk indicator, wherein the risk indicator indicates a likelihood of a presence of a medical condition.
    Type: Grant
    Filed: November 6, 2017
    Date of Patent: February 14, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11567070
    Abstract: A method for collection and dissemination of biologic data, comprising collecting at least one biologic sample by a testing device including thereon an alignment target and including a plurality of immunoassay test strips, wherein the at least one biologic sample contacts a sample pad on at least one of the plurality of immunoassay test strips, assigning correlative values as test results, wherein each test performed on the biologic sample is assigned a different correlative value, receiving the test results at a server disposed on a network, wherein the server has configured thereon a database, assigning a unique identification to the biologic sample, storing the unique identification in the database, storing the test results in the database in association with the unique identification of the biologic sample, and providing access to the database to healthcare organizations for analysis of the test results.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: January 31, 2023
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Publication number: 20220415512
    Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.
    Type: Application
    Filed: September 6, 2022
    Publication date: December 29, 2022
    Inventors: Jovan Hutton PULITZER, Henry Joseph LEGERE, III
  • Patent number: 11527324
    Abstract: An artificial intelligence response system comprises a centralized system having associated therewith a trained database, a tends engine, and a plurality of patient records, a plurality of interconnected entities connected over a network to the centralized system, and a voice-activated assistant device connected over the network to the centralized system and to the interconnected entities, the voice-activated assistant device including a memory operatively coupled to a processor, wherein the processor is configured to receive medical information pertaining to a patient's health from the centralized system, request a treatment regimen for the patient from the centralized system, receive a voice command from a medical professional to retrieve additional medical information, request additional medical information in response to the voice command, and request one or more actions related to treating a patient.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: December 13, 2022
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11468991
    Abstract: A method for providing diagnostic test results is provided. The method comprises providing a software application to be stored on a mobile device, the mobile device having a camera and a viewing screen, initiating operation of the camera, aligning the camera with a visual trigger associated with the diagnostic test, capturing an image of the diagnostic test, sending the image to a server, creating a pixel value array from the pixel values in the image, providing the pixel value array as inputs in a trained neural network, and providing either a positive or negative result from the trained neural network in response to the pixel value array.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: October 11, 2022
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11437142
    Abstract: A method of signaling a medical response action comprises receiving a biofluidic input from a client or application, by a logical testing unit, wherein the logical testing unit comprising a testing display and a persistent testing mechanism, further wherein the persistent testing mechanism comprising one or more analogical data processors, generating one or more logical results from the processing of biofluidic data from the biofluidic input, displaying, on the testing display of the logical testing unit, the one or more logical results, capturing the logical indicators on the testing display with a mobile computing unit, generating, by the mobile computing unit, a pixelated result and an action result, displaying, on the mobile display, the pixelated result and action result, responsive to a signaling input from the client or application, the mobile computing unit processes, by one or more processors, the signaling input and generating an action response packet.
    Type: Grant
    Filed: November 10, 2018
    Date of Patent: September 6, 2022
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11412931
    Abstract: A method for image processing medical self-test results receives a digital image of a self-test result generated by a self-test device. The digital image is processed using generalized curve field transforms to extract relevant geometrical features of the digital image to create a transformed image that is not distorted by distortions of the digital image. The transformed image is displayed for use in a medical diagnosis.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: August 16, 2022
    Assignee: RELIANT IMMUNE DIAGNOSTICS, INC.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III, Hans Kristian Sandberg
  • Publication number: 20220165427
    Abstract: A system providing diagnostic test results to a telemedicine provider includes a server coupled to a network and a memory coupled to the server. The server receives a diagnostic test identifier from a mobile device. The server determines diagnostic test results of a diagnostic test and determines if the diagnostic test results include a positive result. The server stores the diagnostic test results on the server disposed on the network. If the diagnostic test result is determined to include a positive result the server initiates a telemedicine conference between the mobile device and a telemedicine provider, sends the diagnostic test results from the server to the telemedicine provider responsive to initiation of the telemedicine conference and sends additional medical history information from the server to the telemedicine provider responsive to initiation of the telemedicine conference.
    Type: Application
    Filed: February 8, 2022
    Publication date: May 26, 2022
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III